ADMA
ADMA BIOLOGICS, INC.
ADMA BIOLOGICS, INC. (ADMA) has 10 SEC Form 4 filings (23 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 29, 2026.
The most active filer is Director Grossman Jerrold B with 3 filings.
- Industry:Biotechnology
- CEO:Adam S. Grossman
- Employees:685
- HQ:Ramsey, NJ, US
- IPO:2013-10-17
Insider Buying
$468K
reported purchases (SEC code P)
Insider Selling
$476K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$2.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 6,400 | $51K | May 28 | SEC ↗ | |
| Director | Purchase | 12,500 | $100K | May 14 | SEC ↗ | |
Grossman Jerrold BFirst filing | Director | Purchase | 12,500 | $100K | May 12 | SEC ↗ |
Grossman Adam SFirst filing | President and CEO | Sale | 21,000 | $318K | Mar 17 | SEC ↗ |
Kestenberg-Messina Kaitlin M.First filing | COO and SVP, Compliance | Sale | 10,096 | $158K | Mar 10 | SEC ↗ |
ELMS STEVEFirst filing | Director | Purchase | 7,000 | $110K | Mar 9 | SEC ↗ |
ELMS STEVEFirst filing | Director | Purchase | 7,000 | $108K | Mar 9 | SEC ↗ |
Related companies
ADMA BIOLOGICS, INC. is in the Healthcare sector.